Comments
Shares of UPL will remain in investors’ focus, as the company on Friday announced the acquisition of Arysta Life Science Inc for $4.2 billion. The acquisition will enhance its position as a global leader in the agriculture solutions market and will make it a $5-billion entity in combined sales. The all-cash deal agreement to acquire Arysta Life Science Inc and its subsidiaries is between UPL Corporation, the international arm of UPL, and NYSE-listed Platform Specialty Products Corporation.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.